 |
| Monday, 23 January 2012, 09:00 HKT | |
| |  | |
Source: Pharma Regulatory Affairs | |
|
|
|
Singapore, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.
Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.
Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.
In China, what's the impact of the healthcare system reform on pharma companies?
In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?
In Vietnam, what is the regulation framework for drug registration and product commercialisation?
In Indonesia, what are the new regulations related to pre-market evaluation?
The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.
Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.
About IQPC
Defining powerful niche-course topics or problem-specific topics was a skill that was integrated into the structure of Penton Learning Systems. Knowledge is the business as much as the customer is the business. Successful planning is always based on maximizing opportunities. And the need for designing, developing and marketing conferences in niche-based topics became quite apparent. On the foundations of the university and college consortium business, IQPC was born in 1989.
From Small Beginnings...
IQPC now has offices in major cities across six continents including: Berlin, Dubai, London, New York, Sao Paulo, Singapore, Stockholm, Sydney and Toronto. IQPC leverages a global research base of best practices to produce an unrivaled portfolio of problem-solving conferences. Visit www.iqpc.com.
Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg
Jan 23, 2012
Source: Pharma Regulatory Affairs
Topic: Press release summary
Sectors: Trade Shows General, Biotech & Pharm
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2012 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
|
|
|
 |
